QHSLab, Inc.
USAQ · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.10 | 0.33 | 0.12 | 0.00 |
| FCF Yield | 0.12% | 5.36% | -1.77% | 2.05% |
| EV / EBITDA | 33.19 | 115.38 | 176.29 | 38.66 |
| Quality | ||||
| ROIC | 16.09% | 2.04% | -1.19% | 6.56% |
| Gross Margin | 66.97% | 65.90% | 66.61% | 65.84% |
| Cash Conversion Ratio | 0.08 | -2.40 | 0.62 | -0.19 |
| Growth | ||||
| Revenue 3-Year CAGR | 24.28% | 23.20% | 22.64% | 19.70% |
| Free Cash Flow Growth | -97.95% | 356.38% | -190.01% | 197.31% |
| Safety | ||||
| Net Debt / EBITDA | 10.92 | 35.22 | 62.58 | 14.26 |
| Interest Coverage | -1.53 | 0.18 | -0.18 | 0.20 |
| Efficiency | ||||
| Inventory Turnover | 9.15 | 4.88 | 7.38 | 5.12 |
| Cash Conversion Cycle | -76.02 | -117.44 | -93.76 | -97.73 |